Comparative evaluation levobupivacaine and bupivacaine for cesarean section under spinal anaesthesia.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2023/04/051661
- Lead Sponsor
- MLB Medical College, Jhansi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Category 3 and 4 ceserean section
Exclusion Criteria
Patient refusal, contraindication to spinal anaesthesia, allergy to local anesthetics, fused spine , musculoskeletal abnormalities, coagulation defects.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of levobupivacaine and bupivacaine in spinal anesthesia for cesarean sections?
How does the comparative effectiveness of hyperbaric levobupivacaine and bupivacaine impact postoperative pain management in category 3 and 4 cesarean sections?
Which biomarkers are associated with optimal patient selection for spinal anesthesia using hyperbaric local anesthetics in obstetric surgery?
What are the known adverse events and management strategies for hyperbaric levobupivacaine versus bupivacaine in high-risk cesarean deliveries?
How do hyperbaric levobupivacaine and bupivacaine compare to other local anesthetics in terms of safety and efficacy for spinal anesthesia in obstetrics?